Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Research into Oral Semaglutide and Heart Failure Outcomes
February 2026
The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.
Read more
1
Mins
17 Oct 2019
Summary of Artificial Intelligence in Echocardiography for Standard Clinical Metrics
This study sought to validate the use of artificial intelligence (AI) for analysis of an echocardiogram, in a clinical scenario.
4
Mins
17 Oct 2019
ESC 2019 Interview: Prof Thomas F. Lüscher
Prof Thomas F. Lüscher, MD, FRCP, FESC | Professor of Cardiology, Imperial College London, National Heart and Lung Institute, London, UK
2
Mins
17 Oct 2019
Generating Proliferative Induced Cardiomyocyte Precursor Cells
Ischaemic injury of the adult human heart results in irreversible loss of cardiomyocytes (CM), leading to fibrosis, and eventually heart failure.
1
Mins
17 Oct 2019
Out-of-Hospital Cardiac Arrest - Incidence of Coronary Artery Disease, Comorbidity, and Survival
Data from the 2012 European Cardiovascular Disease Statistics show that 20% of all deaths are caused by coronary artery disease (CAD), with cardiac arrest..
1
Mins
17 Oct 2019
Single-Centre Experience with Different Regimes of Antiplatelet Therapy and Oral Anticoagulation in Transcatheter Aortic Valve Replacement
Antithrombotic therapy in transcatheter aortic valve replacement (TAVR) is highly controversial. Dual antiplatelet therapy (DAPT) for 3–6 months…
9
Mins
17 Oct 2019
Icosapent Ethyl for the Prevention of Cardiovascular Events
Based on genetic evidence, it is now known that triglyceride-rich lipoproteins lead to atherosclerosis and local inflammation, which can result in…
5
Mins
17 Oct 2019
Why the Diagnosis of ATTR-Cardiomyopathy May Be a Challenge for Physicians
Cardiac amyloidosis is a rare but life-threatening group of disorders caused by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue.
1
Mins
17 Oct 2019
Analysing the Regulation of a Catecholamine-Dependent Altered cAMP Signalling in a Patient-Specific Induced Pluripotent Stem Cell Takotsubo-Model
The aim of the study was to prove the hypothesis of a phosphodiesterase (PDE)-dependent regulation of 3’,5’-cyclic adenosine monophosphate (cAMP)…
Loading posts...
« Previous
1
…
62
63
64
65
66
…
96
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View